about
Complete mitochondrial DNA diversity in IraniansDistinguishing the co-ancestries of haplogroup G Y-chromosomes in the populations of Europe and the CaucasusHLA class II (DRB1, DQA1 and DQB1) associated genetic susceptibility in Iranian multiple sclerosis (MS) patientsSensitization to common allergens among patients with allergies in major Iranian cities: a systematic review and meta-analysis.The Royan Public Umbilical Cord Blood Bank: Does It Cover All Ethnic Groups in Iran Based on HLA Diversity?Rare large homozygous CFTR gene deletion in an Iranian patient with cystic fibrosis.Inhibition of NR2B-Containing N-methyl-D-Aspartate Receptors (NMDARs) in Experimental Autoimmune Encephalomyelitis, a Model of Multiple SclerosisThe phylogenetic and geographic structure of Y-chromosome haplogroup R1aHLA class II similarities in Iranian Kurds and Azeris.KIR gene content diversity in four Iranian populations.The genetic relationship among Iranian ethnic groups: an anthropological view based on HLA class II gene polymorphism.Origin and spread of human mitochondrial DNA haplogroup U7.Natural Killer Cell Cytotoxicity Against SKOV3 after HLA-G Downregulation by shRNA.Protective Effect of Edaravone Against Cyclosporine-Induced Chronic Nephropathy Through Antioxidant and Nitric Oxide Modulating Pathways in Rats.Immunomodulatory Properties of Taranjebin (Camel's Thorn) Manna and Its Isolated Carbohydrate Macromolecules.Modulatory effects of thymol and carvacrol on inflammatory transcription factors in lipopolysaccharide-treated macrophages.Immunomodulatory properties of Trehala manna decoction and its isolated carbohydrate macromolecules.Hyperthermia increases natural killer cell cytotoxicity against SW-872 liposarcoma cell line.Effect of thermal stress on MICA/B induction in a human liposarcoma cell line.Genetic Analysis of Southwestern Iranian Patients with Familial Mediterranean Fever.Indoor Dust Allergen Levels in the Homes of Patients with Childhood Asthma: An Experience From Southwestern Iran.Increased risk of horse sensitization in southwestern Iranian horse riders.The significance of HLA typing in transplantation.Decreased levels of canonical transient receptor potential channel 3 protein in the rat cerebral cortex after chronic treatment with lithium or valproate.Association between serotonin transporter gene polymorphisms and childhood asthma.Germline BRCA1 mutations in Iranian women with breast cancer.p53 gene alteration and protein expression in Iranian women with infiltrative ductal breast carcinoma.Serotonin transporter gene polymorphisms in Southwestern Iranian patients with irritable bowel syndrome.Genetic connections among Turkic-speaking Iranian ethnic groups based on HLA class II gene diversity.Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in the Fars province of Iran.High variability of TLR4 gene in different ethnic groups in Iran.Increased efficiency in geographic ancestry assignment and human identification by combining lineage profiles: The case of the Iranians.Attitudes of medical students and staff toward organ donation in cases of brain death: a survey at Shiraz University of Medical Sciences.Screening of patients with juvenile idiopathic arthritis and those with rheumatoid arthritis for celiac disease in southwestern Iran.Animal allergen sensitization in veterinarians and laboratory animal workers.Effects of omega-3 fatty acids on serum levels of T-helper cytokines in children with asthma.An evolutionary approach to the medical implications of the tumor necrosis factor receptor superfamily member 13B (TNFRSF13B) gene.Association of HLA-DQA1*0101/2 and DQB1*0502 with myasthenia gravis in southern Iranian patients.Exon-1 polymorphism of ctla-4 gene in Iranian patients with Graves' diseaseHLA-DBR 1 alleles and the susceptibility of Iranian patients with breast cancer
P50
Q24599393-E9FE4A65-5262-483E-8132-A0CE01AA6EAFQ28266672-28E57548-BBEF-4C29-A8D3-675857E2DBCBQ28285705-BF17AD7D-FD6D-4893-92C6-0B71F57B8C88Q30236038-BE336ADE-2180-4201-9E5B-F0A2FDE96EDBQ33456542-4DA26E1C-A43C-4D69-A8BD-2C15B1297DBFQ34047641-F785CF1A-CC4E-4E2B-B0B8-96BA861C03AEQ34146191-8CA9DED3-3D39-4AF5-B1CB-CE2D5C06A9A4Q34412008-0E7E392B-F092-47F5-BC9D-0E58535AE525Q34713609-30B112CC-32F4-4A2C-ACB5-EBE8AE3C5606Q37252058-A9BB8B5D-D542-4F9D-A948-9AB4A70A8F4EQ37315559-6A608FE1-EF83-407E-A98F-83EB91DE25A3Q37741283-CE1CACB9-2722-427D-8BDC-1426DEA42A6CQ38743576-1B33B7D5-2AE3-423D-AF93-CDFF3FE97C44Q38866113-7C495F5D-F6D0-4972-B1A6-8324E3101619Q38887960-514EFDFE-2479-424F-AD75-C842C8E3E028Q38894719-13328ED1-4F6F-4C90-B877-90A83D611693Q38922116-540DCD9C-653A-4A9C-A1B5-DEC9D65CE4FBQ39133244-A81B7E60-B430-49F7-A0AA-D079D674B9ADQ39179726-E9415DF6-F97E-4251-B03E-435916BD5DFFQ40062818-8D50F4B1-5C09-40AF-9448-93ACD5F187ABQ40793835-B5DD339A-A3C1-4631-8B09-31A63B40ADF5Q41532119-9AF4DBA8-8907-49BB-B127-305AAFEBCDCCQ41861336-0A890D64-7DE5-41C1-9EE0-AF0B68E565DDQ41959298-98AA8AA9-CCC2-4F82-AA57-42BD658852B5Q43502176-5E96E622-1175-4099-8B97-55F57BC16E0DQ43542131-3202C594-303B-4883-B8D4-2F7E37ABAD60Q43643342-C03B3737-ED2F-4289-ADF3-8029B4EE62CAQ43881431-23A1479A-420F-4F16-9A7A-585CD7994E61Q43966787-21D00685-C0A8-4767-B854-A7D0444BE5ABQ44371939-D2FE0400-F485-461D-B19F-8548FE2AEF13Q47258615-84BD44FB-F4EC-4C78-AFE7-D0944BB26991Q47676480-A43E56A3-BD56-4432-A9F0-5404E5E2951CQ50714281-33DE2049-95EF-478F-9216-F3A7648A3303Q51324312-A43F9246-CD41-42CC-9E8F-E8B811036F54Q51705370-0605F764-7751-4EAB-A3D9-40EA0C3A74A6Q51708168-EBD62BFA-DF80-413F-9173-855C88F1472FQ52839374-0F6DE970-9819-492B-90C4-2EAECC9A27A4Q54475627-C59CE6BF-7D03-4F59-8E2E-A1A7F51A2B42Q56903817-9C1F2E12-CF4E-4C11-BACA-CD332A2EEB9FQ73873522-D62F446B-AEBB-45B4-940A-002A60D70D9B
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Shirin Farjadian
@ast
Shirin Farjadian
@en
Shirin Farjadian
@es
Shirin Farjadian
@nl
type
label
Shirin Farjadian
@ast
Shirin Farjadian
@en
Shirin Farjadian
@es
Shirin Farjadian
@nl
prefLabel
Shirin Farjadian
@ast
Shirin Farjadian
@en
Shirin Farjadian
@es
Shirin Farjadian
@nl
P106
P31
P496
0000-0002-1369-8466